Liu Xiaopeng, Hu Zhixiong, Zhang Qi
Department of Respiratory Medicine, Jinshan Hospital, Fudan University, Shanghai, China.
Department of Oncology, Jinshan Hospital, Fudan University, 1508 LongHang Road, Jinshan District, Shanghai, China.
BMC Pulm Med. 2025 Sep 1;25(1):417. doi: 10.1186/s12890-025-03908-2.
Gut microbiota dysbiosis plays a vital role the pathogenesis of chronic obstructive pulmonary disease (COPD). This study aimed to: (1) examine the cross-sectional association between dietary index for gut microbiota (DI-GM), a novel biomarker reflecting gut microbiota composition and function, and COPD prevalence; and (2) assess the prognostic significance of DI-GM score for all-cause mortality in COPD patients.
We analyzed data from the 1999-2018 National Health and Nutrition Examination Survey. DI-GM score was calculated from 24-hour dietary recall. Primary outcomes were COPD prevalence and all-cause mortality risk in COPD patients. Multivariable logistic regression assessed the association between DI-GM and COPD prevalence, while Cox proportional hazards models evaluated all-cause mortality risk in COPD patients.
The prevalence of COPD was 6.87% among the 22,859 participants included. Compared to participants with DI-GM score of 0-3, the odds ratio (95% confidence interval) for DI-GM score of 4, 5, and ≥ 6 were 0.88 (0.70-1.11), 0.78 (0.64-0.97), and 0.75 (0.62-0.90), respectively. During a median follow-up time of 84 months, a total of 570 (28.15%) participants died among the 1,580 COPD participants. Compared to DI-GM score of 0-3, the hazard ratios (95% confidence intervals) for DI-GM score of 4, 5, and ≥ 6 were 0.78 (0.60-1.01), 0.63 (0.47-0.83), and 0.69 (0.56-0.85), respectively.
Higher DI-GM scores are significantly associated with both reduced COPD prevalence and improved survival in COPD patients. Our results suggest dietary modifications targeting gut microbiota may represent a novel strategy for COPD prevention and management.
肠道微生物群失调在慢性阻塞性肺疾病(COPD)的发病机制中起着至关重要的作用。本研究旨在:(1)研究反映肠道微生物群组成和功能的新型生物标志物——肠道微生物群饮食指数(DI-GM)与COPD患病率之间的横断面关联;(2)评估DI-GM评分对COPD患者全因死亡率的预后意义。
我们分析了1999 - 2018年国家健康与营养检查调查的数据。DI-GM评分通过24小时饮食回忆计算得出。主要结局是COPD患病率和COPD患者的全因死亡风险。多变量逻辑回归评估DI-GM与COPD患病率之间的关联,而Cox比例风险模型评估COPD患者的全因死亡风险。
在纳入的22,859名参与者中,COPD患病率为6.87%。与DI-GM评分为0 - 3的参与者相比,DI-GM评分为4、5和≥6的比值比(95%置信区间)分别为0.88(0.70 - 1.11)、0.78(0.64 - 0.97)和0.75(0.62 - 0.90)。在中位随访时间84个月期间,1580名COPD参与者中共有570名(28.15%)参与者死亡。与DI-GM评分为0 - 3相比,DI-GM评分为4、5和≥6的风险比(95%置信区间)分别为0.78(0.60 - 1.01)、0.63(0.47 - 0.83)和0.69(0.56 - 0.85)。
较高的DI-GM评分与降低COPD患病率和改善COPD患者生存率均显著相关。我们的结果表明,针对肠道微生物群的饮食调整可能是COPD预防和管理的一种新策略。